Analysts forecast that Tivity Health Inc (NASDAQ:TVTY) will announce sales of $153.72 million for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Tivity Health’s earnings, with the highest sales estimate coming in at $156.00 million and the lowest estimate coming in at $148.51 million. Tivity Health posted sales of $140.97 million during the same quarter last year, which would indicate a positive year over year growth rate of 9%. The business is expected to announce its next quarterly earnings results on Thursday, April 26th.
On average, analysts expect that Tivity Health will report full-year sales of $153.72 million for the current financial year, with estimates ranging from $614.10 million to $620.26 million. For the next year, analysts anticipate that the firm will report sales of $673.84 million per share, with estimates ranging from $649.92 million to $684.78 million. Zacks’ sales averages are a mean average based on a survey of analysts that cover Tivity Health.
Tivity Health (NASDAQ:TVTY) last announced its earnings results on Thursday, February 22nd. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.32 by $0.09. Tivity Health had a return on equity of 29.17% and a net margin of 11.44%. The business had revenue of $139.40 million for the quarter, compared to analyst estimates of $138.22 million. During the same period in the previous year, the company earned $0.35 earnings per share. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year.
TVTY has been the subject of several research analyst reports. Zacks Investment Research raised Tivity Health from a “hold” rating to a “strong-buy” rating and set a $45.00 price objective for the company in a report on Wednesday, February 28th. BidaskClub raised Tivity Health from a “hold” rating to a “buy” rating in a report on Tuesday, March 6th. Chardan Capital reissued a “neutral” rating and issued a $41.00 price objective (down from $44.00) on shares of Tivity Health in a report on Friday, February 23rd. Cantor Fitzgerald reissued an “overweight” rating and issued a $53.00 price objective on shares of Tivity Health in a report on Friday, February 23rd. Finally, Barrington Research boosted their price objective on Tivity Health from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Friday, February 23rd. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $46.88.
Shares of Tivity Health (TVTY) opened at $40.55 on Friday. The firm has a market capitalization of $1,625.21, a PE ratio of 26.85, a P/E/G ratio of 1.72 and a beta of 0.27. Tivity Health has a fifty-two week low of $27.30 and a fifty-two week high of $48.50.
In other news, CEO Donato Tramuto sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $38.53, for a total transaction of $770,600.00. Following the completion of the transaction, the chief executive officer now directly owns 189,596 shares of the company’s stock, valued at $7,305,133.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 8.42% of the stock is currently owned by corporate insiders.
Large investors have recently bought and sold shares of the company. LS Investment Advisors LLC grew its holdings in shares of Tivity Health by 170.9% during the fourth quarter. LS Investment Advisors LLC now owns 3,338 shares of the company’s stock valued at $122,000 after purchasing an additional 2,106 shares during the last quarter. Meadow Creek Investment Management LLC grew its holdings in shares of Tivity Health by 76.4% during the fourth quarter. Meadow Creek Investment Management LLC now owns 3,472 shares of the company’s stock valued at $127,000 after purchasing an additional 1,504 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of Tivity Health during the third quarter valued at approximately $210,000. Macquarie Group Ltd. bought a new position in shares of Tivity Health during the fourth quarter valued at approximately $212,000. Finally, Elkfork Partners LLC bought a new position in shares of Tivity Health during the fourth quarter valued at approximately $222,000.
ILLEGAL ACTIVITY WARNING: “Tivity Health Inc (TVTY) Expected to Post Quarterly Sales of $153.72 Million” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/04/07/tivity-health-inc-tvty-expected-to-post-quarterly-sales-of-153-72-million.html.
About Tivity Health
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Get a free copy of the Zacks research report on Tivity Health (TVTY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.